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The relation of age and body mass index @Ml) to 
atherosclerosis risk factors was examined in 357 
men. Dkler (245 years) men had higher (p <O.Ol) 
systolic and diastolic blood pressures, fasting cho- 
lesterol and gkrcose, and l-hour gk~~se and insulin 
levels. Fasting insulin and triglyceride levels were 
not slgnlficantly different between the 2 age 
groups. Although okler men (n = 170) had greater 
vaW for several risk factors, overweight (BMI 
>2Sd kg/m*) increased risk factors more in men 
younger than 45 years (n = 187). In younger men, 
those with higher BMls had a greater prevalence, 
respsctively, of blood pressue >140/90 mmHg 
(35.2 vs 11.2%, p <O.OOOl), cholesterol X00 
mg/dl(S3.5 vs 26.3%, p <O.OOl), fasting triglyc- 
erides >160 mg/dl(36.0 vs 10.3%, p <O.OOOl), l- 
hour glucose >160 mg/dl(lS.5 vs 5.2%, p <O.OS), 
fasting insulin >l 1 &l/ml (26.2 vs 5.2%, p 
<O.OOOl), and l-hour insulin >llO plVml(26.2 vs 
9.576, p <O.OOl). In contrast, among older men, 
the prevalence of elevated blood pressure, choles- 
terol, triglycerides and glucose values was not sig- 
nificantly greater in the subgroup wfi, high BMI. 
However, elevations of fasting (19.6 vs 6.4%, p 
<O&S) and l-hour insulin (26.3 vs ll.S%, p 
<O.Ol) values were more common among okler 
men with higher BMls. Data indite that older 
men have greater values for several cardiovascular 
risk factors than do younger men. Overweight in- 
creases the prevalence of cardiovascular risk fac- 
tors more in younger men. 
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0 verweight is a risk factor for hypertension,* car- diovascular disease2 and premature death.3 The risk associated with overweight is not uniformly 
distributed. For example, overweight increases the risk 
of cardiovascular disease2 and premature death4 more 
in younger men. These observations may be partially 
explained by data indicating that overweight increases 
the prevalence of hypertension more in younger men.5 
However, to our knowledge, differential effects of over- 
weight on the prevalence of other risk factors in these 2 
groups are unknown. Age-related differences in the ef- 
fects of overweight on cardiovascular risk factor profiles 
in men could have important implications for disease 
prevention. Consequently, we reviewed our risk factor 
data in men to assess the relation of age to the cardio- 
vascular risk of overweight. 
METHODS 
Patie& Data were obtained on 378 men self-re- 
ferred to our Atherosclerosis Risk Factor Detection 
Clinic. Most of the subjects participating in this screen- 
ing process learned about the clinic through newspa- 
per bulletins or from acquaintances familiar with the 
program. 
Measurements: Height and weight were obtained on 
lightly clothed subjects without shoes. Body mass index 
(BMI) was calculated,6 and casual (seated) blood pres- 
sure was measured by mercury sphygmomanometry. 
Diastolic blood pressure was determined by phase IV of 
the Korotkoff sounds. Heart rate was quantified by pal- 
pation of the radial pulse. Blood samples were drawn in 
the fasting state for plasma cholesterol,7 triglycerides,’ 
immunoreactive insulin8 and whole blood glucose.9 Sub- 
jects then drank 100 g of glucose in 10 ounces of water 
over the next 5 minutes. A l-hour blood sample was 
obtained for measurement of whole blood glucose and 
plasma insulin. In 8 patients studied on or after March 
6, 1986, blood glucose was measured in serumlO rather 
than in whole blood. Glucose values from the last 8 per- 
sons were converted to whole blood glucose by the for- 
mula: whole blood glucose = (serum glucose - 6)/ 
1.15.” 
Top normal values (mean + 2 standard deviations 
[SD]) for fasting and l-hour insulin were obtained in a 
subgroup seen in the Atherosclerosis Risk Factor Detec- 
tion Clinic. These 48 subjects (35 men and 13 women) 
were (1) within flO% of ideal body weight, (2) non- 
smokers, (3) physically fit according to self-report of 
moderate to vigorous exercise, (4) normotensive, (5) 
normolipidemic, and (6) normoglycemic.’ ’ No subject 
had a history of hypertension, gout, hyperlipidemia, dia- 
betes, and renal or cardiovascular disease. These sub- 
jects had mean fasting insulin values of 4.3 pU/ml 
(mean + 2 SD = 10.5) and l-hour insulin of 43.2 pU/ 
ml (mean + 2 SD = 110.3). Therefore, 11 and 110 
were selected as top normal fasting and l-hour insulin 
values, respectively. Our values for fasting and l-hour 
postglucose (100 g) insulin levels concur with those ob- 
tained by Bjorntorp et al’* in physically fit, non-over- 
weight men who were 54 to 56 years old. 
Statistical analysis: Twenty-one men with fasting 
glucose > 150 mg/dl or 1 -hour glucose >250 mg/dl or a 
history of diabetes, or any combination of these, were 
eliminated from the analysis, since the insulinemic re- 
sponse of moderate and severe diabetic patients to an 
increase in glucose is significantly impaired.13 Thus, the 
final study group consisted of 357 men. Differences be- 
tween the 2 subgroups of men demarcated by age < vs 
245 years were assessed by Student’s t test. The effect 
of BMI < vs 225.5 kg/m2 within each subgroup on the 
prevalence of selected risk factors was examined with 
chi-square analysis. The triglyceride data were not nor- 
mally distributed.i4 The triglyceride values were loga- 
rithmically transformed to normalize the distribution. 
Data analyses were conducted using established statisti- 
cal programs.15 
RESULTS 
Descriptive variables (mean f standard error of the 
mean) for the 2 groups of men stratified by age < vs 
145 years are listed in Table I. The age limit was 
adapted from the Australian Heart Foundation Study 
which observed a stronger relation between overweight 
and prevalence of hypertension in men <45 years versus 
other age and gender subgroups.5 Older men had great- 
er values than younger men for several risk factors. Ta- 
ble II presents data on men within each age group de- 
marcated by BMI <25.5 vs 125.5 kg/m*. Overweight 
tended to cause larger increases of risk factor levels in 
younger men. 
Table III displays the percentage of men in 4 sub- 
groups stratified by age < or 245 years and BMI < or 
125.5 kg/m* whose values exceeded generally accepted 
top normal levels for the risk factors measured. The 
TABLE I Descriptive Variables for Men Stratiiied by Age < or 
2 45 Years Old 
4% <45 245 
Stratification (n = 187) (n = 170) 
Age (years) 
BMI (kg/m2) 
Systolic BP (mm Hg) 
Diastolic BP (mm Hg) 
HR(beats/min) 
flRl @J/ml) 
l-hour IRI (&J/ml) 
TG (mg/dl) 
fWBG (mg/dl) 
l-hour WBG (mg/dl) 
TC (mg/db 
32.4* 0.5 
25.4 f 0.3 
121 f 1 
81 f 1 
72fl 
5.9 f 0.4 
68f4 
126f8 
91 f 1 
115f2 
190f3 
55.6 f 0.6 





















BMI = body mass Index: BP = blood pressure; f = fasbng; HI? = heart rate; IRI = 
plasma lmmunoreacttve Insulin; NS = not significant (p >0.05); TC = total plasma 
cholesterol: TG = fasttng plasma triglycerides; WBG = whole bloodglucose 
BMI cutpoint was also adapted from the Australian 
Heart Foundation Study which observed a sharp in- 
crease in the prevalence of hypertension among men 
<45 years whose BMI exceeded this value.4 A BMI of 
25.5 kg/m* corresponds to a Metropolitan Relative 
Weight of 109 to 113% according to the 1959 Tables.16 
The risk factor prevalence data in Table III are 
based on the following: 
1. BLOOD PRESSURE: Systemic hypertension was de- 
fined as casual blood pressure I1 40 mm Hg systolic or 
290 mm Hg diastolic, or both (Korotkoff phase IV). 
2. CHOLESTEROL: Cholesterol values 1200 mg/dl 
were defined as elevated based on National Cholesterol 
Education Program guidelinesi 
3. TRIGLYCERIDES: Triglycerides >150 mg/dl were 
considered abnormal, since decreased high-density cho- 
lesterol values are frequent in persons with triglyceride 
concentrations exceeding that level.‘* 
4. FASTING AND ONE-HOUR WHOLE BLOOD GLUCOSE: 
The upper normal limits for fasting and l-hour glucose 
are based on the Fajans-Conn criteria.’ ’ 
5. FASTING AND ONE-HOUR INSULIN: Normal limits 
for fasting and l-hour insulin values are defined in 
Methods. 
Younger (<45 years) overweight men (BMI 125.5 
kg/m2) had a significantly higher prevalence for mea- 






l-hour IRI @J/ml) 
fWf3G (mg/dl) 
l-hour WBG (mg/dl) 
TG (mg/dO 
TC (w/d0 
Abbreviabons as I” Table I. 
Men <45 Years 
<25.5 kg/ma 
(n= 116) 
23.0 f 0.2 
119fl 
78fl 
71 f 1 







(n = 71) 





















Men 245 Years 
<25.5 kg/m2 
(n = 78) 











(n = 92) 
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TABLE III Prevalence (%) of Selected Atherosclerosis Risk 
Factors in Men Stratified by Age and Body Mass Index 
<45 Years 245 Years 
1~41 M/m9 <25.5 225.5 <25.5 225.5 
Risk Factor (n= 116) (n = 71) (n = 78) (n = 92) 
Htn 11 35**** 44 41 
1.7+ 1.4 13 11 
TC 29 54*** 55 65 
0.0s 1.4 2.6 5.4 
TG 10 38***0 28 30 
fWBG 1.7 5.6 2.6 3.3 
l-hour WBG 5.2 15.5* 18 24 
flRl 5.2 2809*” 6.4 20” 
l-hour IRI 9.5 28*** 11.5 298’ 
pvalue~*0.05:**0.01* ***0.001,“=*0.0001bychisquare. 
f Percent takingantihypertensive medications. 
* Percent taking hypolipidemic medications. 
Htn = hypertension; other abbreviations as I” Table I. 
Influence of overweight on risk factor vahres within 
each age group: Overweight younger men had signifi- 
cantly greater values for measured risk factor variables 
except heart rate (Table II). The effect of overweight 
was generally less among older men (Tables II and III 
and Figure 1). Overweight younger men have a cardio- 
vascular risk factor profile (Table III) comparable to _ _ 
sured risk factor variables, except fasting glucose, than older men who are at the greatest absolute risk of car- 
leaner men of similar age (Table III). Older men mani- diovascular disease.2 
fested smaller BMI-related increases in the prevalence 
of risk factors. Figure 1, which is based on data in Table 
Blood pressure: Overweight (BMI >25.5 kg/m2) 
was associated with a threefold higher prevalence of hy- 
III, shows the excess and relative risks of overweight for pertension in younger men. In contrast, overweight was 
selected risk factors separately for younger and older 
men. 
DISCUSSION 
Differences in risk factor values between younger 
and otder men: Men 245 years old had higher values 
than younger men for several risk factors including sys- 
tolic and diastolic blood pressure, fasting cholesterol and 
glucose, and l-hour glucose and insulin.19s20 However, 
other risk factors including BMI,2’ heart rate22 and 
fasting triglyceride23 insulin levels24 were not signifi- 
cantly different between the 2 groups (Table I). 
.- 




Htn Chol Trig F WBG lhr WBG F IRI lhr IRI 
FIGURE 1. Effect of body mass index 
(BMI) on the excess (top pa&J and rela- 
tive (boffofn panof) risk for soloclod car- 
diovascular risk factors in men stratified 
byage.Chol=chokt~F=fadng; 
kltn=hypededoq IRI = plasma immu- 
noroaclive i&n; TRIG = triglycerideq 
wBG=whekbhnMlgh#coso. 
250 THE AMERICAN JOURNAL OF CARDIOLOGY VOLUME 67 
not associated with a significantly greater prevalence of 
hypertension in our sample of men >45 years. These 
data are similar to the findings of the Australian Heart 
Foundation study5 which reported a stronger relation of 
weight to hypertension in men <45 years old compared 
with other age and gender subgroups. Nevertheless, 
overweight may increase the risk of heart failure in both 
younger and older hypertensive subjects by imposing a 
dual burden of elevated preload on a heart working 
against a higher afterload. 
Insulin: An association between weight, insulin and 
hypertension was reported. 26 Insulin levels, per se, are 
an unlikely explanation for the stronger association be- 
tween overweight and hypertension in younger men, 
since overweight increased the prevalence of fasting and 
l-hour hyperinsulinemia in both age groups (Table III, 
Figure 1). However, insulin induces greater neurogenic 
activation in men <40 vs men >60 years old.27 These 
findings could contribute to the greater plasma norepi- 
nephrine and vascular cY-adrenergic tone in overweight 
versus leaner young men.2s Consequently, differences of 
insulin action rather than insulin concentration may ex- 
plain greater effects of overweight on blood pressure in 
younger versus older men. 
Glucose: Older men had higher values for fasting 
and l-hour glucose despite higher l-hour insulin values 
(Table I). This suggests that insulin resistance contrib- 
utes to an age-related decline of glucose tolerance in our 
subjects. The prevalence of fasting hyperglycemia was 
sufficiently low in all subgroups to the extent that no 
significant differences were observed. However, the age- 
corrected prevalence of l-hour hyperglycemia” was sig- 
nificantly increased by overweight only in younger men. 
However, as noted previously, overweight was associ- 
ated with an increase in l-hour hyperinsulinemia in 
both younger and older men (Table III, Figure 1). 
These data suggest that overweight is associated with 
greater resistance to insulin’s effects on glucose disposal 
or suppressing gluconeogenesis, or both, in younger 
men. 
Triglycerides: Younger men had a larger BMI-re- 
lated increase in the prevalence and relative risk of 
hypertriglyceridemia (Table III, Figure 1). However, 
insulin normally suppresses hepatic very low density li- 
poprotein production.29 Thus, a greater weight-related 
hepatic resistance to insulin in younger men may ex- 
plain our triglyceride data. 
Cholesterok Cholesterol levels were higher in older 
men (Table I). Overweight significantly increased the 
prevalence of cholesterol values >200 mg/dl only in 
younger men. The absence of a significant effect of 
overweight on cholesterol values in men 50 to 79 years 
old was documented previously.30 Although the cause 
for these age-related differences is unknown, greater ef- 
fects of overweight on a-adrenergic tone in younger 
men could partially explain these observations.31 
Limitations of this cross-sectional study and com- 
parirrons to previous epideiniologic investigations: 
These data were obtained on self-referred men who may 
not reflect health characteristics of the general male 
population. Since we observed age-related differences in 
the association between weight and several cardiovascu- 
lar risk factors, comparison of BMI values in our sub- 
jects with larger samples of U.S. men is of particular 
interest. The mean f SD BMI values for men aged 30 
to 39 and 50 to 62 years in the National Health and 
Nutrition Survey II were 25.6 f 4.0 and 26.2 f 3.9 kg/ 
m2, respectively. 32 These BMI values are very similar to 
those for the younger and older men in this study (25.4 
f 4.0 and 26.0 f 2.6 kg/m2, respectively). 
The results from our study are consistent in other 
respects with observations from larger surveys. First, in 
the Australian Study,5 the strongest relation between 
weight and blood pressure was observed in men aged 
<45 years. Second, the relatively minimal differences in 
cholesterol between overweight and leaner elderly men 
were also noted previously. 3o Third, whereas older men 
have higher values than younger men for several risk 
factors, our data (Table II) are consistent with reports 
that overweight has greater adverse health effects in 
younger men.2,4,5 In fact, increased cardiovascular risk 
for younger men begins at mild levels of overweight.2,5 
Because the mean BMI for men of this age group (Ta- 
ble I) lies at the margin of increased risk, large numbers 
of younger men are affected.32 
This study did not address potential explanations for 
the greater risk of overweight in younger versus older 
men. The lower apparent risk of overweight in older 
men may reflect premature mortality in younger men 
with high-risk obesity.4.32 Another possibility is that old- 
er men with BMIs K25.5 kg/m2 may have suffi- 
cient adiposity (replacing lean mass) to raise their risk 
factors. 
Our data extend previous observations by showing 
that overweight is associated with a significant increase 
in prevalence not only of elevated blood pressure but 
also of cholesterol, triglycerides and l-hour glucose in 
younger men. The relative risk of overweight for each of 
these variables appears to be less in older men. Over- 
weight is associated with significant elevations of fasting 
and l-hour hyperinsulinemia in both age groups. How- 
ever, our interpretation of the data suggests that over- 
weight influences insulin action more adversely in youn- 
ger men. 
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